Ken-ichiro Kosai
Inventor
Stats
- 0 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 9 US Applications Filed
- 1 Total Citation Count
- Jan 5, 2024 Most Recent Filing
- Sep 28, 2006 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| KAGOSHIMA UNIVERSITY | 1
1 | 2011
2015 |
Inventor Addresses
| Address | Duration |
|---|---|
| Kagoshima, JP | Aug 11, 20 - Aug 01, 24 |
| Kagoshima-shi, JP | Nov 21, 13 - Nov 21, 13 |
| Kagoshima-shi, Kagoshima, JP | Feb 23, 17 - Feb 23, 17 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 8 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
| C07K: | PEPTIDES | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0252,561 | 2024 | THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR BONE AND SOFT TISSUE TUMORS | 0 |
| 2024/0173,381 | 2024 | HB-EGF GENE THERAPY FOR DIABETES | 0 |
| 2024/0148,807 | 2024 | ONCOLYTIC VIRUS (ONCOLYTIC IMMUNOTHERAPY) CAPABLE OF EFFECTIVELY TREATING EVEN METASTATIC CANCER WHILE ENSURING SAFETY, WITH EXPRESSION CONTROL SYSTEM PROVIDING OPTIMAL EXPRESSION LEVEL OF MOUNTED IMMUNOGENIC GENE | 0 |
| 11896635 | 2024 | Oncolytic virus (oncolytic immunotherapy) capable of effectively treating even metastatic cancer while ensuring safety, with expression control system providing optimal expression level of mounted immunogenic gene | 0 |
| 2023/0414,718 | 2023 | LOW-DOSE HEPATOCYTE GROWTH FACTOR GENE THERAPY FOR DIABETES | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.